Body mass index (BMI) Influences the Salutary Effects of Metformin on Survival After Lobectomy for Stage I NSCLC

INTRODUCTION: Metformin, a common medication used in the treatment of Diabetes Mellitus is known to have anti-cancer effects. We hypothesized that the salutary effect of metformin on the survival of patients with stage I NSCLC is influenced by body mass index (BMI). METHODS: Patients undergoing lobe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Oncol
Autors principals: Yendamuri, Sai, Barbi, Joseph, Pabla, Sarabjot, Petrucci, Cara, Punnanitinont, Achamaporn, Nesline, Mary, Glenn, Sean T., Depietro, Paul, Papanicalou-Sengos, Antonios, Morrison, Carl, Dy, Grace K., Elkin, Peter L.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7386563/
https://ncbi.nlm.nih.gov/pubmed/31398539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2019.07.020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars